Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nutrien Ltd (NTR) vs UiPath Inc (PATH) Price & Performance

Nutrien LtdTrade
UiPath IncTrade

Price performance (Past 24H)

Key statistics

Nutrien Ltd vs UiPath Inc — how do they compare? Nutrien Ltd trades at $80.95 (market cap $38.47B), while UiPath Inc trades at $13.63 (market cap $7.26B). The key difference: Nutrien Ltd is far larger — about 5.3× UiPath Inc's market cap, and Nutrien Ltd pays a 2.73% dividend while UiPath Inc pays none. Which is the better fit depends on your goals.

NTRPATH
Market Cap
$38.47B$7.26B
Sector
Basic MaterialsTechnology
52-Week High
$83.94$19.29
52-Week Low
$53.64$9.38
Enterprise Value
$50.28B$6.05B
Dividend Yield
2.73%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nutrien Ltd

Nutrien (NTR) trades at $80.68, up 1.52% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported mixed Q2 2026 earnings, missing EPS estimates but beating on revenue, driven by higher fertilizer prices. Analyst consensus is a Moderate Buy with a $76.17 price target, though recent news includes a downgrade to Hold citing cost pressures and volume constraints. Cash flow trends show consistent operational strength but negative net cash flow in recent years.

The outlook is cautiously optimistic, supported by strong potash and nitrogen demand and institutional buying, but risks include cyclical earnings, rising sulfur costs, and volatile agricultural markets. The stock's current price above the consensus target suggests limited near-term upside, requiring monitoring of cost management and volume recovery for sustained growth.

UiPath Inc

UiPath (PATH) trades at $14.01, down 7.77% amid mixed signals. The stock is near its consensus price target low of $14.00. Revenue growth is improving, with 2025 revenue at $1.43 billion and a projected net profit margin of 21.03% for 2026. Technical indicators show a bearish near-term trend with RSI at oversold levels, while recent news highlights volatility following Q2 earnings.

The outlook is cautious; PATH shows fundamental improvement but faces execution risks and competitive pressure. Analyst consensus is predominantly Hold (70.84%), with a $17.38 price target suggesting modest upside. Key risks include slowing growth guidance and macroeconomic headwinds impacting software demand.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nutrien Ltd

Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

Read more on NTR

About UiPath Inc

UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.

Read more on PATH